Get started
Author

Suneel Chamoli

Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial
2018 · Jerome Sarris, Gerard J Byrne, et al. · Journal of Affective Disorders · 61
Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study
2019 · Jerome Sarris, Gerard J Byrne, et al. · Australian & New Zealand Journal of Psychiatry · 46
Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial,
2018 · Jerome Sarris, Gerard J. Byrne, et al. · European Neuropsychopharmacology · 38
S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial
2019 · Jerome Sarris, Jenifer Murphy, et al. · Psychopharmacology · 37
The feasibility and acceptability of high-intensity interval training for adults with mental illness: A pilot study
2017 · Justin J. Chapman, Jeff S. Coombes, et al. · Mental health and physical activity · 35
PDF
A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder
2011 · Vivek Agarwal, Prabhat Sitholey, et al. · Indian Journal of Psychiatry · 33
Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation
2024 · Salam Hussain, Suneel Chamoli, et al. · Australian & New Zealand Journal of Psychiatry · 26
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial
2022 · Jerome Sarris, Gerard Byrne, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 20
An adjunctive antidepressant nutraceutical combination in treating major depression: Study protocol, and clinical considerations
2015 · Jerome Sarris, Con Stough, et al. · Advances in Integrative Medicine · 19
Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again
2021 · Paul B Fitzgerald, Shane Gill, et al. · Australian & New Zealand Journal of Psychiatry · 13
Treatment of refractory obsessive–compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study
2021 · Jerome Sarris, Gerard J. Byrne, et al. · CNS Spectrums · 12
The place of non-invasive brain stimulation in the RANZCP clinical practice guidelines for mood disorders
2021 · Paul B Fitzgerald, Shane Gill, et al. · Australian & New Zealand Journal of Psychiatry · 12
Prescribing electroconvulsive therapy for depression: Not as simple as it used to be
2023 · Shane Gill, Salam Hussain, et al. · Australian & New Zealand Journal of Psychiatry · 10
Determining the future role of clinical practice guidelines: The experience of Australia and New Zealand
2024 · S Kisely, H Herrman, et al. · Australian & New Zealand Journal of Psychiatry · 3
Electroconvulsive Therapy Credentialing for Psychiatrists—Review of Required Standards Across States and Territories in Australia
2023 · Subramanian Purushothaman, Brett Simpson, et al. · Journal of Ect
Works count: 20
Citation count: 365
H-index: 12
I10-index: 13
Year
Topic
Type